#1 Clinical Trials Search in Europe

Trazodone

Trazodone, a versatile medication used primarily for depression and insomnia, has been the subject of several clinical trials exploring its effectiveness, safety, and various formulations. These studies have investigated trazodone’s impact on sleep quality, cognitive function, and its potential as an alternative to other sleep medications. The trials have also examined different dosages and formulations to optimize its therapeutic effects while minimizing side effects.

Table of Contents

What is Trazodone?

Trazodone is a medication that belongs to a class of drugs called antidepressants. It is known by several brand names, including Desyrel, Oleptro, Beneficat, Deprax, Desirel, Molipaxin, Thombran, Trazorel, Trialodine, Trittico, and Mesyrel[1]. Trazodone is available in different forms, including immediate-release tablets and extended-release caplets[2].

Uses of Trazodone

Trazodone is primarily used to treat various conditions, including:

  • Depression: It is commonly prescribed as an antidepressant to help manage symptoms of depression[3].
  • Insomnia: Trazodone is often used to treat sleep disorders, particularly insomnia, due to its sedative properties[4].
  • Anxiety: Some patients may be prescribed trazodone to help manage anxiety symptoms[4].
  • Postpartum Depression: Research is being conducted to evaluate trazodone’s potential in preventing postpartum depression in women with a history of depression[3].

How Trazodone Works

Trazodone works by affecting certain chemicals in the brain, primarily serotonin. Serotonin is a neurotransmitter (a chemical messenger) that plays a crucial role in regulating mood, sleep, and other important functions. By modulating serotonin levels, trazodone can help improve mood, reduce anxiety, and promote better sleep[2].

Dosage and Administration

The dosage of trazodone can vary depending on the condition being treated and the specific formulation used. Some common dosage forms include:

  • Immediate-release tablets: These are typically taken multiple times a day. For example, some studies have used 100 mg tablets taken three times daily[2].
  • Extended-release caplets: These are designed to be taken once daily, often at bedtime. Dosages can range from 150 mg to 300 mg[2].

It’s important to note that dosages should always be determined by a healthcare provider based on individual patient needs and response to the medication.

Side Effects

Like all medications, trazodone can cause side effects. Common side effects may include:

  • Drowsiness or sleepiness
  • Dizziness
  • Dry mouth
  • Blurred vision
  • Constipation
  • Weight changes

In clinical trials, researchers often use specific tools to measure side effects, such as the Frequency, Intensity, Burden of Side Effects Rating (FIBSER) scale[3]. It’s important to report any side effects to your healthcare provider.

Research and Clinical Trials

Trazodone is the subject of ongoing research to better understand its effects and potential uses. Some areas of current research include:

  • Sleep Apnea: Studies are investigating whether trazodone can help improve adherence to continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea[5].
  • Postpartum Depression Prevention: Researchers are exploring the potential of low-dose trazodone in preventing postpartum depression in women with a history of depression[3].
  • Substance Use Disorders: Some studies are looking at the use of trazodone in patients with dual diagnoses of mental health disorders and substance use disorders[4].
  • Alzheimer’s Disease: Research is being conducted to investigate whether trazodone can improve sleep and cognitive function in patients with early Alzheimer’s disease[6].

Precautions and Considerations

When taking trazodone, it’s important to keep the following in mind:

  • Medical History: Inform your healthcare provider about your complete medical history, especially any history of heart problems, liver disease, or bipolar disorder.
  • Pregnancy and Breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of trazodone use with your doctor[3].
  • Drug Interactions: Trazodone can interact with other medications, including certain antidepressants and blood thinners. Always inform your healthcare provider about all medications you are taking.
  • Alcohol: Avoid alcohol while taking trazodone, as it can increase the sedative effects of the medication.
  • Driving and Operating Machinery: Trazodone can cause drowsiness, so avoid driving or operating heavy machinery until you know how the medication affects you.

Remember, trazodone should only be taken under the guidance of a healthcare professional. Never adjust your dosage or stop taking the medication without consulting your doctor first.

Aspect Details
Formulations studied Extended-release caplets, immediate-release tablets
Dosages investigated 50 mg, 100 mg, 150 mg, 300 mg
Primary uses Insomnia, depression, sleep disorders
Comparison studies Trazodone vs. quetiapine for insomnia in dual diagnosis patients
Special populations Veterans with dual diagnosis, patients with obstructive sleep apnea, individuals with amnestic mild cognitive impairment
Ongoing research Effects on cognition in early Alzheimer’s disease, impact on PAP therapy adherence in sleep apnea patients
Key outcome measures Sleep quality, sleep duration, slow wave sleep, cognitive function, treatment adherence
Safety considerations Side effect profiles at different doses, tolerability in various patient populations

FAQ

  • What is trazodone and what is it used for? Trazodone is a medication primarily used to treat depression and insomnia. It belongs to a class of drugs called serotonin modulators and has been studied for its effects on sleep quality, cognitive function, and as an alternative to other sleep medications.
  • How does trazodone compare to other sleep medications? Some studies have compared trazodone to other sleep medications like quetiapine. For example, one trial investigated whether trazodone could be an adequate substitute for quetiapine in treating insomnia in veterans with dual diagnosis (addiction and mental illness). The results suggested that trazodone might be as effective as quetiapine for maintaining good sleep quality.
  • What dosages of trazodone have been studied in clinical trials? Clinical trials have investigated various dosages of trazodone, ranging from 50 mg to 300 mg. Some studies have compared different formulations, such as extended-release and immediate-release versions. For instance, one trial examined the bioavailability of 300 mg trazodone hydrochloride extended-release caplets versus 100 mg immediate-release tablets.
  • Can trazodone help with sleep apnea? One study explored the potential of trazodone to improve adherence to positive airway pressure (PAP) therapy in patients with obstructive sleep apnea. The trial investigated different doses (50 mg and 100 mg) of trazodone compared to placebo to determine the optimal balance between potential benefits and side effects in improving PAP therapy adherence.
  • Are there any ongoing studies on trazodone for cognitive function? Yes, there is an ongoing study called the REST trial, which is investigating the effect of trazodone on sleep, hippocampal-dependent memory, and hippocampal excitability in patients with amnestic mild cognitive impairment (aMCI) and sleep complaints. This study aims to determine if improving sleep with trazodone can have positive effects on cognition in early Alzheimer's disease.

Ongoing Clinical Trials on Trazodone

  • Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Germany Greece Italy Spain

Glossary

  • Bioavailability: The extent and rate at which a drug enters the body's circulation and becomes available at the site of action.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Extended-release: A formulation of a drug designed to release the active ingredient slowly over time, allowing for less frequent dosing.
  • Immediate-release: A formulation of a drug designed to release the active ingredient quickly after administration.
  • Crossover study: A type of clinical trial where participants receive different treatments in a specific order, allowing each participant to serve as their own control.
  • Placebo: An inactive substance that looks like the drug being tested, used as a control in clinical trials to determine the true effects of the active drug.
  • Obstructive Sleep Apnea (OSA): A sleep disorder characterized by repeated episodes of complete or partial obstruction of the upper airway during sleep.
  • Positive Airway Pressure (PAP) therapy: A treatment for sleep apnea that uses a machine to deliver pressurized air through a mask to keep the airway open during sleep.
  • Amnestic Mild Cognitive Impairment (aMCI): A condition characterized by memory problems that are noticeable but do not interfere significantly with daily activities, often considered an early stage of Alzheimer's disease.
  • Slow Wave Sleep (SWS): A deep stage of non-rapid eye movement sleep characterized by slow brain waves, important for physical restoration and memory consolidation.

References

  1. https://clinicaltrials.gov/study/NCT00253890
  2. https://clinicaltrials.gov/study/NCT01121926
  3. https://clinicaltrials.gov/study/NCT05299398
  4. https://clinicaltrials.gov/study/NCT01662297
  5. https://clinicaltrials.gov/study/NCT02945644
  6. https://clinicaltrials.gov/study/NCT05282550